Human umbilical cord-derived mesenchymal stem cell therapy (Guangzhou Saliai)

人脐带间充质干细胞（广州赛莱拉）

Report date: 2025/06/06 20:01:13

Base Information

Drug NameHuman umbilical cord-derived mesenchymal stem cell therapy (Guangzhou Saliai)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapyCell and gene therapy > Cell therapy > Source of cells > Umbilical cord-derived
Mechanisms of ActionStem cell replacements
TargetsNot applicable
Therapy Area/IndicationsOsteoarthritis, Knee
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesGuangzhou Saliai Stemcell Science And Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesGuangzhou Saliai Stemcell Science And Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, Knee
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A